M. Durante

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari et al. · Gastroenterology · 2019 · 221 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors

Anthony W. Tolcher, Johanna C. Bendell, Kyriakos P. Papadopoulos et al. · Annals of Oncology · 2014 · 126 citations · Full text

Medicine, Oncology, Pharmacology +13

First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies

Pamela N. Münster, Rahul Aggarwal, David S. Hong et al. · Clinical Cancer Research · 2015 · 112 citations · Full text

Medicine, Oncology, Pharmacology +15